2015
DOI: 10.1016/j.phrs.2015.05.008
|View full text |Cite
|
Sign up to set email alerts
|

Novel frontiers in calcium signaling: A possible target for chemotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
19
0

Year Published

2015
2015
2018
2018

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 20 publications
(20 citation statements)
references
References 28 publications
1
19
0
Order By: Relevance
“…The major findings of this study are that (i) venetoclax (ABT-199) does not dysregulate This is in contrast to several other stress inducers, including apoptotic stimuli like ceramide and chemotherapeutic/anti-cancer drugs [42,43]. Recently, fast and constitutive changes in cytosolic Ca 2+ levels have been proposed as early markers for the detection of cytotoxicity in response to H 2 O 2 , staurosporin, As 2 O 3 , gossypol and titanium(IV)-salane complexes in different cancer cell models [44].…”
Section: Discussionmentioning
confidence: 84%
See 1 more Smart Citation
“…The major findings of this study are that (i) venetoclax (ABT-199) does not dysregulate This is in contrast to several other stress inducers, including apoptotic stimuli like ceramide and chemotherapeutic/anti-cancer drugs [42,43]. Recently, fast and constitutive changes in cytosolic Ca 2+ levels have been proposed as early markers for the detection of cytotoxicity in response to H 2 O 2 , staurosporin, As 2 O 3 , gossypol and titanium(IV)-salane complexes in different cancer cell models [44].…”
Section: Discussionmentioning
confidence: 84%
“…Moreover, in cisplatin-resistant ovarian cancer cells, ABT-737 can also promote the formation of ERmitochondrial contact sites induced by cisplatin, thereby augmenting cisplatin-induced Ca 2+ rise in the mitochondria and apoptosis [38]. These observations further underpin the intimate link between the effective response to anti-cancer therapeutics and efficient ER-mitochondrial Ca 2+ transfer [43,46,49].…”
Section: Discussionmentioning
confidence: 90%
“…The major intracellular Ca 2+ storage unit is the ER (luminal [Ca 2+ ] ER 500 μM-1 mM)3, which exhibits significant heterogeneity in the Ca 2+ level among its sub-regions. Upon stimulation with agonists such as histamine or ATP, the ER rapidly releases Ca 2+ through the inositol 1,4,5-trisphosphate receptor (IP3R), thereby generating transient waves in the cytoplasm and mitochondria to promote cell activities45. Upon ER Ca 2+ depletion, the luminal sensor protein STIM1 oligomerizes on the ER membrane and migrates to sites of ER/PM interaction to activate the highly Ca 2+ -selective ORAI channels located on the PM67.…”
mentioning
confidence: 99%
“…Many cell death-inducing agents, like H 2 O 2 (86, 87), arachidonic acid (88), ceramide (50, 86), and menadione (89, 90) have been shown to act at the ER by triggering Ca 2+ release through IP 3 Rs and subsequently provoking mitochondrial Ca 2+ rises (91). Moreover, the ability of chemotherapeutics, like adriamycin (77), arsenic trioxide (71), and mitotane (82) and of photodynamic therapy (78) to kill cancer cells strongly depends on their ability to adequately induce ER–mitochondrial Ca 2+ transfer (92). The spectrum of chemotherapeutics acting in this way might be quite broad, since recently it was shown that cisplatin and topotecan increase [Ca 2+ ] cyt over time, although [Ca 2+ ] mt was not determined (93).…”
Section: Mitochondrial Ca2+ Signals As Regulators Of Cell Death and Smentioning
confidence: 99%
“…Moreover, FATE1 expression is also inversely correlated with the overall survival of adrenocortical cancer patients (82). Oppositely, enhancing ER–mitochondrial Ca 2+ transfer will favor cell-death therapies (92). Interestingly, some anticancer drugs might actually impact ER–mitochondrial contact sites and thereby enhance the response to other chemotherapeutics.…”
Section: Er–mitochondrial Ca2+ Signaling Underlying Cellular Senescenmentioning
confidence: 99%